Ownership history in XTX Topco Ltd · 11 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in CARDIFF ONCOLOGY INC (CRDF). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 219,357 | +63,196 | +40.5% | 0.02% | $616K | $2.81 |
| 2025 Q3 | ADDED | 156,161 | +25,809 | +19.8% | 0.02% | $322K | $2.06 |
| 2025 Q2 | ADDED | 130,352 | +89,589 | +219.8% | 0.02% | $411K | $3.15 |
| 2024 Q4 | REDUCED | 40,763 | -79,621 | -66.1% | 0.01% | $177K | $4.34 |
| 2024 Q3 | ADDED | 120,384 | +36,947 | +44.3% | 0.02% | $321K | $2.67 |
| 2024 Q2 | ADDED | 83,437 | +49,984 | +149.4% | 0.02% | $185K | $2.22 |
| 2023 Q4 | REDUCED | 33,453 | -21,628 | -39.3% | 0.01% | $50K | $1.48 |
| 2022 Q2 | ADDED | 55,081 | +29,927 | +119.0% | 0.05% | $121K | $2.20 |
| 2022 Q1 | ADDED | 25,154 | +11,330 | +82.0% | 0.03% | $62K | $2.48 |
| 2021 Q3 | REDUCED | 13,824 | -1,063 | -7.1% | 0.03% | $92K | $6.66 |
As of 2025 Q4 — sorted by position size